Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure [NA]
Clinical trial update documenting completed study on the effects of chronic ACE and DPP-4 inhibition on blood pressure in adults with type 2…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension [Phase 3]
Phase 3 trial evaluating enalapril folic acid tablets with a calcium channel blocker or diuretic to prevent stroke in patients with type H h…
-
FDA approval · 2021-07-19FDA Approved: NIFEDIPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's nifedipine generic through an original ANDA, covering common indications such as hypertension and an…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Stop Atherosclerosis in Native Diabetics Study [Phase 4]
Phase 4 trial update for a study aimed at stopping atherosclerosis in native diabetics; results completed with posting in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Scripps Wired for Health Monitoring Study [NA]
A completed clinical trial by Scripps Translational Science Institute with results posted; conditions include diabetes and hypertension with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) [NA]
Clinical trial on chloroquine for reducing atheroma in patients with metabolic syndrome has completed with results posted.
-
FDA approval · 2021-06-23FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Mylan Pharmaceuticals. The drug is traditionally used to tre…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women [Phase 2]
Phase 2 trial investigating the effect of beetroot juice on blood pressure regulation in postmenopausal women has completed with results pos…
-
FDA approval · 2021-06-22FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA has approved a supplemental application for CARDURA XL (doxazosin mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic fixed-dose combination tablet irbesartan and hydrochlorothiazide. The product is man…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the irbesartan and hydrochlorothiazide fixed-dose combination, expanding its approved use for tr…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE from Teva Pharmaceuticals USA, Inc., indicating a labelin…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the generic irbesartan and hydrochlorothiazide combination from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension [Phase 2]
Phase 2 trial evaluating LCI699 versus placebo in resistant hypertension completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension [Phase 4]
A Phase 4 trial comparing high-dose statin plus telmisartan versus amlodipine evaluating effects on glucose metabolism in patients with athe…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension [Phase 2]
Phase 2 trial evaluating the effects of LCI699 on cortisol in participants with hypertension has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study [NA]
The SPYRAL PIVOTAL HTN-OFF MED trial has completed and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Perioperative Blood Pressure Screening to Improve Long-term Cardiovascular Health [NA]
A completed clinical trial evaluating perioperative blood pressure screening to improve long-term cardiovascular health; results posted in 2…
-
FDA approval · 2021-05-21FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic irbesartan and hydrochlorothiazide combination from Aurobindo Pharma Limited.
-
FDA approval · 2021-05-21FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE from Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension [Phase 3]
Phase 3 trial update on long-term use of valsartan in young children with hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) [Phase 4]
Phase 4 clinical trial update for azelnidipine in hypertensive patients with coronary atherosclerosis using serial volumetric IVUS analysis.
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals' generic candesartan cilexetil and hydrochlorothiazide combination …
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application to market a generic candesartan cilexetil and hydrochlorothiazide combination product for hypertensi…
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for candesartan cilexetil and hydrochlorothiazide from Mylan Pharmaceuticals, authorizing its us…